Login / Signup

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.

Beverly M K BillerCharlotte HöybyePaul V CarrollMurray B GordonAnna Camilla BirkegårdNicky KelepourisNavid NedjatianMatthias M Weber
Published in: Pituitary (2021)
ClinicalTrials.gov NCT00960128 (date of registration: August 13, 2009) and NCT01009905 (date of registration: November 5, 2009).
Keyphrases
  • pregnancy outcomes
  • replacement therapy
  • growth hormone
  • pregnant women
  • smoking cessation
  • quality improvement
  • polycystic ovary syndrome
  • type diabetes
  • metabolic syndrome
  • case control
  • insulin resistance